Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

ESAB Corporation Analysts Bullish on Stock Growth

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Stifel analyst Nathan Jones is bullish on ESAB (NYSE: ESAB), maintaining a Buy rating and increasing the price target to $114 as of March 1, 2024. ESAB Corporation has reached a 52-week high, with an estimated fair value of US$95.57 based on 2 Stage Free Cash Flow to Equity analysis.

Over the past 3 months, ESAB Corporation has seen an average price target of $94.80, with 8 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings for the current month. ESAB specializes in fabrication technology and gas control solutions, offering cutting-edge equipment, consumables, gas control devices, robotics, and digital solutions for various industries.

Analysts predict a stock price forecast of $87.14 for ESAB, with an average rating of “Buy”. Furthermore, ESAB reported revenue of $2.59 billion in 2022, reflecting a 6.81% increase from the previous year.

ESAB Stock Rises 2.10% on Strong Performance and Positive Market Sentiment

ESAB stock had a strong performance on March 1, 2024, as it continued to trade near the top of its 52-week range and above its 200-day simple moving average. The stock price increased by $2.04 since the market last closed, representing a 2.10% rise from the previous closing price of $99.12.

In pre-market trading, ESAB shares continued to climb, rising by an additional $0.83. This positive price momentum indicates that investors are optimistic about the company’s future prospects.

ESAB, a leading manufacturer of welding and cutting equipment, has been benefiting from strong demand in the construction, manufacturing, and infrastructure sectors. The company’s innovative products and strong customer relationships have helped it maintain a competitive edge in the market.

Investors are also optimistic about ESAB’s growth prospects, as the company continues to expand its product offerings and enter new markets. With a strong balance sheet and solid financial performance, ESAB is well-positioned to capitalize on opportunities for growth and deliver value to its shareholders.

Overall, ESAB stock’s strong performance on March 1, 2024, reflects the company’s solid fundamentals and positive market sentiment. Investors may want to keep an eye on ESAB as it continues to demonstrate its ability to generate value and drive shareholder returns.

ESAB Stock Performance Reflects Mixed Financial Results – March 1, 2024

ESAB, a leading global manufacturer of welding and cutting equipment, has seen its stock performance on March 1, 2024, reflect its recent financial results. According to data from CNN Money, ESAB reported total revenue of $2.77 billion for the past year, with a quarterly revenue of $689.35 million. In terms of net income, ESAB reported a net income of $205.28 million for the past year, with a quarterly net income of $58.32 million. Earnings per share (EPS) for ESAB were reported at $3.36 for the past year and $0.83 for the last quarter. Overall, the financial results for ESAB indicate a mixed performance for the company. While total revenue has seen a slight increase, net income and EPS have both experienced declines. Investors should carefully monitor ESAB’s financial performance and consider the potential risks before making any investment decisions.

Tags: ESAB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mining technology

Stifel Analyst Reiterates Buy Rating on Hewlett Packard Enterprise with Adjusted Price Target

Finance_Assets (3)

Anticipation Builds for Paymentus Holdings Quarterly Earnings Report

Finance_ blue chart

Investors Guide to Crescent Energys Quarterly Earnings What to Watch for on March 4 2024

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com